Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients

Despite remarkable progress in melanoma therapy, the exceptional heterogeneity of the disease has prevented the development of reliable companion biomarkers for the prediction or monitoring of therapy responses. Here, we show that difficulties in detecting blood-based markers, like circulating tumor...

Full description

Bibliographic Details
Main Authors: Katharina Gorges, Lisa Wiltfang, Tobias M. Gorges, Alexander Sartori, Lina Hildebrandt, Laura Keller, Beate Volkmer, Sven Peine, Anna Babayan, Ingrid Moll, Stefan W. Schneider, Sören Twarock, Peter Mohr, Jens W. Fischer, Klaus Pantel
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Cancers
Subjects:
melanoma
ctdna
ctc
liquid biopsy
Online Access:https://www.mdpi.com/2072-6694/11/11/1685

Internet

https://www.mdpi.com/2072-6694/11/11/1685

Similar Items